International Federation of Clinical Chemistry and Laboratory Medicine Advancing excellence in laboratory medicine for better healthcare worldwide www.ifcc.org Annual Report 2019 Highlights of the Year • EuroMedLab Congress, Barcelona, ES – May 2019 (http://euromedlab.org/) • 24th Congreso Latinoamericano de Bioquímica Clínica – COLABIOCLI Congress, Panamá – September 2019 • 15th Asia-Pacific Federation of Clinical Biochemistry and Laboratory Medicine (APFCB) Congress, Jaipur (India), November 2019 • 6th African Federation of Clinical Chemistry (AFCC) Congress, Marrakech (Morocco), September 2019 • New Task Force Corporate Members (TF-CM) formed • IFCC VLP programme supported by Abbott (http://www.ifcc.org/ifcc-education-division/emd-special-projects/) • IFCC Speakers’ Bureau (https://www.ifcc.org/media/478033/ifcc-speakers-bureau-rev-12- may-2019.pdf • Roche/IFCC Travel Scholarships • IFCC Professional Scientific Programmes (PSEP/PMEP) • IFCC FEN - Foundation for Emerging Nations (http://www.ifccfoundation.org/) • Webinars and Distance Learning Modules (http://www.ifcc.org/ifcc-education-division/webinars/ifcc-webinars/) • Task Force Young Scientists (TF-YS) webinars http://www.ifcc.org/task-force-young-scientists-web-pages/tf-ys-webinars/ • IFCC Expert Database (http://www.ifcc.org/ifcc-education-division/experts/) • The IFCC Curriculum, Phase 1 released in Vietnamese (http://www.ifcc.org/media/477266/ejifcc2018vol29no1pp055-093.pdf)) • e-Academy, open educational resources (http://eacademy.ifcc.org/) • eJIFCC available in Google Scholar • eJIFCC available in Scopus • CPD C-IeL and EMD C-DL re-established again from former C-IDL • IFCC Flow cytometry courses (http://www.ifcc.org/ifcc-education-division/working- groups-special-projects/httpifccorghostinginsoftdkmedia46789217_phd_course_program_ bpdf/) • DQCML Projects in Kazakhstan (http://www.ifcc.org/ifcc-education-division/working- groups-special-projects/developing-quality-competence-in-medical-laboratories-dqcml/ • Implement cooperation and agreements with IFCC Regional Federations 2 Index Message from IFCC President _____________________________________________________ 4 Executive Board __________________________________________________________________ 5 Treasurer Report _________________________________________________________________ 6 Corporate Members _____________________________________________________________ 11 Committee on Congresses and Conferences (C-CC) _______________________________ 13 Scientific Division (SD) ___________________________________________________________ 15 Education and Management Division (EMD) _______________________________________ 43 Communications and Publications Division (CPD) __________________________________ 52 Emerging Technologies Division (ETD) ____________________________________________ 60 Task Forces _____________________________________________________________________ 64 FEN - Foundation for Emerging Nations ___________________________________________ 69 Federations _____________________________________________________________________ 71 • AFCB - Arab Federation of Clinical Biology ______________________________________ 71 • AFCC - African Federation of Clinical Chemistry__________________________________ 74 • APFCB - Asia-Pacific Federation of Clinical Biochemistry and Laboratory Medicine and Laboratory Medicine ___________________________________ 76 • COLABIOCLI - Latin-American Confederation of Clinical Biochemistry ______________ 78 • EFLM – European Federation of Clinical Chemistry and Laboratory Medicine ________ 85 • NAFCC - North American Federation Of Clinical Chemistry & Laboratory Medicine ___ 91 Full Member Societies ___________________________________________________________ 92 Affiliate Member Societies ______________________________________________________ 149 3 Message from the President of IFCC The IFCC mission ‘Advancing excellence in laboratory medicine for better healthcare worldwide’ has been the guiding principle for our work in 2019. The 2019 was a very sad year for IFCC community with the sudden death of the President Prof. Howard Morris. As a result, I was very honored to be asked to serve again in the role of President. It is a great pleasure to thank the Executive Board for the support during this challenging time. All members contributed their valuable knowledge, experience, and insight from around the world. In 2019 we followed the 2018-2020 Strategic Plan developed under the guidance of Prof. Morris. The 2018-2020 strategic plan supports the principle of maintaining the IFCC as the as the most respected international resource of expertise for the improvement of patient care through laboratory medicine. There were a number of significant achievements in 2019, as a result of the efforts of the Divisions, Committees, Working Groups and Task Forces made up of volunteers from our member organizations. These achievements are summarized in the various reports from the functional groups below. My thanks to all of these groups and their volunteers for the excellent work they have done. Some highlights of our strategic plan and achievements are summarized below. We established the EMD Committee for the Value Proposition in Laboratory Medicine (C-VPLM) to advocate the adoption of the value proposition in laboratory medicine, and develop tools that can be used to establish the value of medical tests within the healthcare system in terms of financial impact and patient outcomes. The CPD eAcademy continues its efforts to provide a quality, comprehensive curriculum in laboratory medicine via 20 to 40 minute webinars, with learning points and a certifiable assessment. Currently these are largely available in English although collaborations are underway to increase the Spanish language presentations. Perhaps more important is utilization of the eAcademy by national societies or perhaps local area branches of national societies. These webinars are an excellent tool to bring together younger or trainee clinical laboratory specialists with one or two more experienced practitioners to listen to the presentation, discuss the learning points and then individually undertake the assessment. Learning together is always a more enjoyable experience. The excellent work of the Scientific Division in collaboration with the Joint Committee for Traceability in Laboratory Medicine (JCTLM) and the International Consortium for Harmonization of Clinical Laboratory Results (ICHCLR) and other metrology and reference material manufacturers continues to expand the standardization and harmonization of clinical laboratory assays. This is a key strategy to ensure accuracy or at least harmonization of results of medical tests for optimal medical practice. During the next period the IFCC will be working with metrology institutes, both regional and national, to enhance collaboration and avoid duplication of the preparation of certified reference materials. This has been identified as the current requirement 4 for the profession in order to take the next steps in our long-term strategy. A significant accomplishment in 2019 was the EuroMedLab, held in Barcelona, Spain, May 19th – May 23rd. The Congress was extremely successful with more than 6,300 participants coming from 117 different countries. I thank all IFCC officers for their invaluable service throughout 2019 as described in their specific reports below. My sincere thanks also to the member organizations: full, associate and corporate members, for their continued support of the IFCC and for the individuals that they nominate to the IFCC functional groups. A special thanks to Professor Dave Kinniburgh for his invaluable work throughout 2019. I wish to thank the IFCC Office Staff, Paola Bramati, Silvia Cardinale and Silvia Colli-Lanzi for their dedicated efforts in managing the day-to-day business of the IFCC, and for their personal assistance to me as President. Prof. Maurizio Ferrari EXECUTIVE BOARD (EB) The IFCC Executive Board held three meetings during 2019. The first meeting was held in Hammamet, Tunisia on February 2-4, in conjunction with the STBC meeting; the second EB meeting was held in Barcelona, Spain on May 19, 24-25, in conjunction with EuroMedLab; and the third EB meeting was held in Jaipur, India on November 20-22 in conjunction with the APFCB Congress. A few of the highlights of 2019 are summarized below. In order to strengthen the collaboration between IFCC and its Corporate Members and to better address their specific needs and challenges, the EB created a new IFCC Task Force - Corporate Members (TF-CM) that will report directly to the IFCC Executive Board. The IFCC was invited to attend a WHO meeting and established a line of communication with the WHO that will facilitate input to the WHO in the future. In an order to address inequities in member dues, the EB received approval from Council to set the dues for Affiliate members. The IFCC EuroMedLab was held in Barcelona on May 19-23, 2019 and was a very successful congress, providing an excellent educational and professional networking experience for all delegates. Recognizing the importance of Young Scientists to the future of IFCC and the practice of Laboratory Medicine, the EB established a policy requiring all Committees to have at least one Young Scientist. Mathias Müller and Bernard Gouget are reviewing the archived IFCC documents to prepare an updated History of the IFCC. The newly established Emerging Technologies Division was active in establishing the Committee for Emerging Technologies in Pediatric